CD8a/CD8b Jurkat Cell Line
The CD8a/CD8b Jurkat Cell Line are human T lymphocyte Jurkat cells (Clone# E6-1) engineered to express CD8a (NM_ 001768.6) and CD8b (NM_004931.5) driven by an EF1a promoter. The cells were generated by transduction with CD8a/CD8b Lentivirus (BPS Bioscience #78650), which is a SIN (self-inactivating) lentivirus. The cells also express very low levels of endogenous CD4.
Purchase of this cell line is for research purposes only; commercial use requires a separate license. View the full terms and conditions.
Name | Ordering Information |
Thaw Medium 2 | BPS Bioscience #60184 |
Growth Medium 2E | BPS Bioscience #79638 |
The cell line has been screened to confirm the absence of Mycoplasma species.
CD8 (cluster of differentiation 8) is a cell surface glycoprotein found on most cytotoxic T lymphocytes that functions within the immune system to mediate cell-cell interactions. CD8 is a co-receptor for the TCR (T cell receptor) in T cells, binding to MHC (major histocompatibility complex) class I proteins. CD8 is a typical marker of cytotoxic T cells and is involved in signaling. CD8 has two isoforms, a and b. CD8b recruits Lck (lymphocyte-specific protein tyrosine kinase) to the TCR-CD3 complex, and Lck phosphorylates multiple proteins involved in activation of cytotoxic T lymphocytes. It is thus critical for the lysis of cancer cells. Studying CD8 and its importance in iso-immunity can further our understanding of post-transplant recognition and its potential for cancer therapy.